A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1283 and mRNA-1273 (variant formulations) within the current epidemiological environment
Epistemonikos ID: dcac786df598974506a77cbee928f326ecbd3e91
First added on: Oct 08, 2026